Mutations of the β2-microglobulingene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptides-Reference-Cited by-同舟云学术

Mutations of the β2-microglobulingene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptides

Published:1998-12 Issue:6 Volume:52 Page:520-529
ISSN:0001-2815
Container-title:Tissue Antigens
language:en
Short-container-title:

Author:

Benitez R.,Godelaine D.,Lopez-Nevot M.A.,Brasseur F.,Jimenez P.,Marchand M.,Oliva M.R.,Baren N.,Cabrera T.,Andry G.,Landry C.,Ruiz-Cabello F.,Boon T.,Garrido F.

Publisher

Wiley

Subject

Genetics,Biochemistry,Immunology,General Medicine,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1399-0039.1998.tb03082.x/fullpdf

Reference24 articles.

1. T-cell defined tumor antigens;Eynde;Curr Opin Immunol,1997

2. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma;Bruggen;Science,1991

3. Structure, chromosomal localization and expression of twelve genes of the MAGE family;Plaen;Immunogenetics,1994

4. Human gene MAGES codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes;Gaugler;J Exp Med,1994

5. Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3;Marchand;Int J Cancer,1995

Cited by 127 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NLRC5/MHC class I transactivator: A key target for immune escape by SARS‐CoV‐2;BioEssays;2024-03-10

2. Neoadjuvant personalized cancer vaccines: the final frontier?;Expert Review of Vaccines;2024-01-10

3. MHC/HLA Class-I Loss and Cancer Immune Escape;The Major Histocompatibility Complex (MHC/ HLA) in Medicine;2024

4. Cancer—avoiding immune detection;Clinical Immuno-Oncology;2024

5. Strategies to overcome low MHC-I expression in paediatric and adult tumours;Immunotherapy Advances;2023-12-11